IBS - Review and what's new

Amy Foxx-Orenstein

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal motility disorder broadly characterized by abdominal pain/discomfort associated with altered bowel habits. The chronic and bothersome nature of IBS symptoms often negatively affects patient quality of life and activity level and places a substantial economic burden on patients and the healthcare system. Advances in research have led to a greater understanding of the underlying pathophysiology of IBS, particularly regarding the role serotonin plays in the gastrointestinal tract; the development of stepwise, symptom-based diagnostic strategies that allow for a diagnosis of IBS to be made without the need for extensive laboratory testing; and the development of treatment options targeting underlying pathophysiologic mechanisms that provide relief of the multiple symptoms associated with IBS. This review highlights recent advances in research and discusses how these findings can be applied to daily clinical practice.

Original languageEnglish (US)
JournalMedGenMed Medscape General Medicine
Volume8
Issue number3
StatePublished - 2006

Fingerprint

Irritable Bowel Syndrome
Gastrointestinal Motility
Research
Abdominal Pain
Habits
Gastrointestinal Tract
Serotonin
Economics
Quality of Life
Delivery of Health Care

ASJC Scopus subject areas

  • Medicine(all)

Cite this

IBS - Review and what's new. / Foxx-Orenstein, Amy.

In: MedGenMed Medscape General Medicine, Vol. 8, No. 3, 2006.

Research output: Contribution to journalArticle

Foxx-Orenstein, A 2006, 'IBS - Review and what's new', MedGenMed Medscape General Medicine, vol. 8, no. 3.
Foxx-Orenstein, Amy. / IBS - Review and what's new. In: MedGenMed Medscape General Medicine. 2006 ; Vol. 8, No. 3.
@article{7ed9406b3d6041418919d9dc2c135415,
title = "IBS - Review and what's new",
abstract = "Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal motility disorder broadly characterized by abdominal pain/discomfort associated with altered bowel habits. The chronic and bothersome nature of IBS symptoms often negatively affects patient quality of life and activity level and places a substantial economic burden on patients and the healthcare system. Advances in research have led to a greater understanding of the underlying pathophysiology of IBS, particularly regarding the role serotonin plays in the gastrointestinal tract; the development of stepwise, symptom-based diagnostic strategies that allow for a diagnosis of IBS to be made without the need for extensive laboratory testing; and the development of treatment options targeting underlying pathophysiologic mechanisms that provide relief of the multiple symptoms associated with IBS. This review highlights recent advances in research and discusses how these findings can be applied to daily clinical practice.",
author = "Amy Foxx-Orenstein",
year = "2006",
language = "English (US)",
volume = "8",
journal = "MedGenMed : Medscape general medicine",
issn = "1531-0132",
publisher = "Medscape Health Network",
number = "3",

}

TY - JOUR

T1 - IBS - Review and what's new

AU - Foxx-Orenstein, Amy

PY - 2006

Y1 - 2006

N2 - Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal motility disorder broadly characterized by abdominal pain/discomfort associated with altered bowel habits. The chronic and bothersome nature of IBS symptoms often negatively affects patient quality of life and activity level and places a substantial economic burden on patients and the healthcare system. Advances in research have led to a greater understanding of the underlying pathophysiology of IBS, particularly regarding the role serotonin plays in the gastrointestinal tract; the development of stepwise, symptom-based diagnostic strategies that allow for a diagnosis of IBS to be made without the need for extensive laboratory testing; and the development of treatment options targeting underlying pathophysiologic mechanisms that provide relief of the multiple symptoms associated with IBS. This review highlights recent advances in research and discusses how these findings can be applied to daily clinical practice.

AB - Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal motility disorder broadly characterized by abdominal pain/discomfort associated with altered bowel habits. The chronic and bothersome nature of IBS symptoms often negatively affects patient quality of life and activity level and places a substantial economic burden on patients and the healthcare system. Advances in research have led to a greater understanding of the underlying pathophysiology of IBS, particularly regarding the role serotonin plays in the gastrointestinal tract; the development of stepwise, symptom-based diagnostic strategies that allow for a diagnosis of IBS to be made without the need for extensive laboratory testing; and the development of treatment options targeting underlying pathophysiologic mechanisms that provide relief of the multiple symptoms associated with IBS. This review highlights recent advances in research and discusses how these findings can be applied to daily clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=33746887448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746887448&partnerID=8YFLogxK

M3 - Article

C2 - 17406160

AN - SCOPUS:33746887448

VL - 8

JO - MedGenMed : Medscape general medicine

JF - MedGenMed : Medscape general medicine

SN - 1531-0132

IS - 3

ER -